Annual report [Section 13 and 15(d), not S-K Item 405]

License Agreements (Tables)

v3.25.1
License Agreements (Tables)
12 Months Ended
Dec. 31, 2024
License Agreements  
Schedule of License Agreements

 

Licensor   Drug Asset   Agreement Date   Amendment Date
Elion Oncology, Inc.   NGC-Cap (PCS6422)   August 23, 2020   May 17, 2022
Ocuphire Pharma, Inc.   NGC-Gem (PCS3117)   June 16, 2021   N/A
Aposense, Ltd.   NGC-Iri (PCS11T)   May 24, 2020   N/A
Yuhan Corporation   PCS12852   August 19, 2020   N/A
CoNCERT Pharmaceuticals, Inc.   PCS499   March 19, 2018   N/A